Stocksigma LogoStocksigma Logo

Symbiotec Pharmalab Board to Consider Q1 FY27 Results on 21st Sep'26

Symbiotec Pharmalab Limited has scheduled a Board of Directors meeting on 21st Sep'26 to consider and approve the unaudited standalone and consolidated

Symbiotec Pharmalab Board to Consider Q1 FY27 Results on 21st Sep'26

Symbiotec Pharmalab Ltd 路 Intimation 路 21 Sept 2026, 5:30 am

Symbiotec Pharmalab Board to Consider Q1 FY27 Results on 21st Sep'26 Symbiotec Pharmalab Limited has scheduled a Board of Directors meeting on 21st Sep'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter ended 30th Jun'26. Additionally, the trading window for dealing in company securities by designated persons and their immediate relatives remains closed until 48 hours following the formal declaration of the results.

Original exchange filing (PDF)

More announcements from Symbiotec Pharmalab Ltd

All Symbiotec Pharmalab Ltd announcements